Comparison of Aptima and hybrid capture-2 HPV tests and Pap test in the referral population in Japan.

The Aptima human papillomavirus (HPV) test (APTIMA) detects E6-E7 mRNA in abnormal cells in the uterine cervix. To investigate the accuracy of APTIMA for cervical cancer screening in Japan, 423 subjects, mostly referrals with abnormal cytology or being followed up for cervical intraepithelial neoplasia (CIN)1, were screened using two HPV tests, hybrid capture 2 (HC2) and APTIMA, and by the Pap test. Colposcopy was conducted in all subjects with a positive result in either test type.

Survey on the trends in uterine cervical cancer screening in Japanese women: the efficacy of free coupons in the screening.

Aims: In Japan, cytological examination is performed for uterine cervical cancer screening, but the rate of participation in these programs is low. Between October 1, 2009 and March 31, 2010, free coupons for uterine cervical cancer screening were distributed to Japanese women. The Fukuoka Tuberculosis Prevention Center investigated the trends in uterine cervical cancer screening participation of Japanese women in the 6-month screening program.

Legionella impletisoli sp. nov. and Legionella yabuuchiae sp. nov., isolated from soils contaminated with industrial wastes in Japan.

In this study, we tried to isolate legionellae from nine Legionella DNA-positive soil samples collected from four different sites contaminated with industrial wastes in Japan. Using culture methods with or without Acanthamoeba culbertsoni, a total of 22 isolates of legionellae were obtained from five of the nine samples. Identification of species and/or serogroups (SGs), performed by DNA-DNA hybridization and agglutination tests, revealed that the 22 isolates consisted of ten isolates of Legionella pneumophila including five SGs, five Legionella feeleii, and one each of Legionella dumoffii, Legionella longbeachae, and Legionella jamestownensis.

Low-grade endometrial stromal sarcoma recurring with multiple bone and lung metastases: report of a case.

Background: Approximately 50% of patients with low-grade endometrial stromal sarcoma (ESS) develop recurrent disease, mainly in lung or pelvis. Bone metastasis of low-grade ESS is an extremely rare phenomenon.

Case: A 63-year-old Japanese female developed multiple bone and lung metastases 18 years after initial treatment for low-grade ESS.